Briefly
Live preview · United States

Legal and Regulatory intelligence for you

Legal News
United States
Case Law

Lexington Medical: Medtronic Antitrust Lawsuit Over Surgical Staplers

Medtronic, a global medical device manufacturer, has been hit with a federal antitrust lawsuit by Massachusetts-based Lexington Medical, accusing it of engaging in monopolistic practices to illegally shut out competition in the market for laparoscopic surgical staplers. This lawsuit carries significant legal implications for the medical device industry, highlighting the ongoing scrutiny of dominant market players under federal antitrust laws. For practitioners, it underscores the risks associated with aggressive market strategies that may be perceived as exclusionary or anti-competitive, particularly in highly specialized and critical healthcare sectors. Businesses, especially smaller innovators like Lexington Medical, will be watching closely as the outcome could influence market access and competitive dynamics, potentially leading to more equitable playing fields or reinforcing existing market structures. The allegations of restrictive agreements, bundling, and long-term contracts are common themes in antitrust litigation and could set precedents for how such practices are evaluated in the medical technology space. The legal context for this case is rooted in federal antitrust law, primarily the Sherman Act and potentially the Clayton Act, which prohibit monopolization and anti-competitive agreements. The lawsuit alleges that Medtronic maintains over 90% market share in laparoscopic staplers and uses this dominance to prevent rivals from competing. The claim references a previous federal antitrust case where Medtronic was ordered to pay $382 million in damages for unlawful monopoly over blood-vessel sealing devices, suggesting a pattern of behavior that could be relevant to the current proceedings. The federal court system will apply established antitrust jurisprudence to determine if Medtronic's actions constitute illegal exclusionary conduct rather than legitimate competition. The key parties involved are Lexington Medical, the plaintiff, a Massachusetts-based company specializing in laparoscopic universal handle staplers, and Medtronic, the defendant, a global medical device manufacturer headquartered in Minnesota. The lawsuit was filed in a federal court, though the specific district is not mentioned in the excerpt. The allegations center on Medtronic's alleged restrictive agreements with client hospitals and its efforts to prevent trials of rival products. Attorneys advising medical device companies, healthcare providers, or businesses in highly concentrated markets should closely monitor the progress and eventual outcome of this antitrust suit. It serves as a critical reminder of the potential legal challenges arising from market dominance and the importance of ensuring that commercial strategies comply with federal antitrust regulations. Businesses should review their contracting practices, bundling arrangements, and market conduct to mitigate risks of similar litigation, especially if they hold significant market share. The outcome of this matter is not yet reported in the excerpt.

6 Nov
United States
Case Law

Ninth Circuit: NFL Sunday Ticket Reversal Overturns Expert Exclusion

The Ninth Circuit Court of Appeals, on Friday, reversed a trial court's judgment in favor of the National Football League (NFL) in an antitrust lawsuit brought by Sunday Ticket subscribers, sending the case back to the U.S. District Court in Los Angeles for a new trial solely on damages. This unanimous decision by the appellate panel overturned the district judge's post-verdict ruling, which had set aside a jury's $4.7 billion award against the NFL. The Ninth Circuit found that U.S. District Judge Philip Gutierrez had abused his discretion by improperly excluding the plaintiffs' expert witness testimony, which subsequently led to an erroneous grant of judgment as a matter of law for the NFL. This ruling carries significant legal implications for antitrust litigation, particularly concerning the admissibility of expert testimony under Federal Rule of Evidence 702 and the *Daubert* standard. The Ninth Circuit's emphasis on the district court's gatekeeping role, while cautioning against conflating reliability with credibility, reinforces the high bar for excluding expert evidence. For practitioners, this decision highlights the critical importance of robust expert witness preparation and the potential for appellate review to scrutinize trial judges' discretion in evidentiary matters, especially in complex cases involving substantial damages. It signals that courts of appeal will closely examine whether expert testimony was excluded based on its perceived merits rather than its foundational reliability. The legal context for this case involves federal antitrust law, specifically the Sherman Act, which prohibits anti-competitive agreements and monopolization. The procedural posture is an appeal from a judgment as a matter of law (JMOL) under Federal Rule of Civil Procedure 50, following a jury verdict. The Ninth Circuit's decision hinges on the proper application of the *Daubert* standard for expert testimony admissibility, which requires trial judges to ensure that expert testimony is based on reliable methods applied to sufficient facts. The appellate court's finding of an abuse of discretion in excluding expert testimony directly impacted the viability of the subscribers' antitrust claims, necessitating a remand for further proceedings. The key parties involved are the National Football League (NFL) as the defendant, and the subscribers to its Sunday Ticket package as the plaintiffs. The case originated in the U.S. District Court in Los Angeles, presided over by the now-retired U.S. District Judge Philip Gutierrez. The appellate review was conducted by a panel of the Ninth Circuit Court of Appeals, with U.S. Circuit Judge Anthony Johnstone authoring the unanimous decision. The original jury had awarded $4.7 billion in damages, which the district judge subsequently set aside. Attorneys and businesses involved in complex litigation, particularly antitrust cases, should closely monitor the proceedings on remand and the eventual outcome of the new damages trial. This decision underscores the need for meticulous preparation and defense of expert testimony, as its exclusion can be a dispositive issue. Practitioners should review their strategies for qualifying and challenging expert witnesses, understanding that appellate courts will scrutinize the basis for exclusion. Furthermore, businesses facing antitrust claims should be aware that initial trial victories based on evidentiary exclusions may not withstand appellate review, necessitating a long-term litigation strategy that accounts for potential reversals and remands.

30 Oct